Evidence map›Paper›PMID 26120563›Full record

ArticleCurrent opinion in insect science2015

Disruption of dengue virus transmission by mosquitoes.

Alexander W E Franz, Velmurugan Balaraman, Malcolm J Fraser

Open access · greenAbstract read
In one paragraph

Article in Current opinion in insect science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Alexander W E FranzDepartment of Veterinary Pathobiology, 303 Connaway Hall, College of Veterinary Medicine, University of Missouri, Columbia MO, 65211, United States of America.
Velmurugan BalaramanDepartment of Veterinary Pathobiology, 303 Connaway Hall, College of Veterinary Medicine, University of Missouri, Columbia MO, 65211, United States of America.
Malcolm J FraserDepartment of Biological Sciences, 218 Galvin Life Science Bldg., University of Notre Dame, South Bend IN, 46617, United States of America.
Missouri College · USUniversity of Notre Dame · US

Funding

Transgenic engineering of Aedine mosquitoesR01AI048561 · NIAID · UNIVERSITY OF NOTRE DAME · PI FRASER, MALCOLM J. · 2001 to 2005
$1.8M
Transgenic Resistance of Aedes aegypti to the Four Serotypes of Dengue VirusR21AI112782 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI FRANZ, ALEXANDER W E · 2014 to 2015
$384k
NIAID NIH HHS R01 AI048561NIAID NIH HHS R21 AI112782
6 · The paper itself

Abstract

Current control efforts for mosquito-borne arboviruses focus on mosquito control involving insecticide applications, which are becoming increasingly ineffective and unsustainable in urban areas. Mosquito population replacement is an alternative arbovirus control concept aiming at replacing virus-competent vector populations with laboratory-engineered incompetent vectors. A prerequisite for this strategy is the design of robust anti-pathogen effectors that can ultimately be genetically driven through a wild-type population. Several anti-pathogen effector concepts have been developed that target the RNA genomes of arboviruses such as dengue virus in a highly sequence-specific manner. Design principles are based on long inverted-repeat RNA triggered RNA interference, catalytic hammerhead ribozymes, and trans-splicing Group I Introns that are able to induce apoptosis in virus-infected cells following splicing with target viral RNA.

Indexed as

Aedes aegyptiantiviral effector genecatalytic hammerhead ribozymedengue virusRNA interferencetrans-splicing Group I Intron

Identifiers

PMID26120563
PMCPMC4480767
OpenAlexW2024586415

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.